Cardiovascular risk according to plasma apolipoprotein and lipid profiles in a Canadian First Nation* N. D. Riediger, MSc (1); S. G. Bruce, PhD (1); T. K. Young, MD, PhD (2) * This article is part of a joint publication

First Page		Document Content
Date: 2011-06-29 11:30:21 Apolipoproteins Cardiology Lipoproteins Nutrition Sterols Apolipoprotein A1 High-density lipoprotein Apolipoprotein B Low-density lipoprotein Health Chemistry Medicine		Cardiovascular risk according to plasma apolipoprotein and lipid profiles in a Canadian First Nation* N. D. Riediger, MSc (1); S. G. Bruce, PhD (1); T. K. Young, MD, PhD (2) * This article is part of a joint publication Add to Reading List Source URL: www.phac-aspc.gc.ca Download Document from Source Website File Size: 223,51 KB Share Document on Facebook

	MOHAMAD NAVAB, Ph.D. CURRICULUM VITAE PERSONAL HISTORY: Cardiology/Medicine A2-237 CHS, UCLA DocID: 1rez7 - View Document
	928 ORIGINAL ARTICLE More hostile dyslipidaemia in chronic kidney disease patients on maintenance haemodialysis than on conservative management Teerath Kumar Rathi,1 Murtaza Fakhruddin Dhrolia,2 Salman Imtiaz3 DocID: 1r32P - View Document
	Nutrition & Metabolism This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon. Bio F1B hamster: a unique animal model DocID: 1qwiu - View Document
	A CETP polymorphism improves diagnostic power of clinical examination in patients with cardiovascular disease DocID: 1qsIb - View Document
	Studies in Patients with Kidney Diseases Principal Investigator: Florian Kronenberg Background: Patients with chronic kidney disease have one of the highest risks known for atherosclerotic complications. They have furthe DocID: 1qmQY - View Document